| Impact of COVID-19 on GU Disease (NCT04761107) | Icahn School of Medicine at Mount Sinai | 2021-02-18 |
| Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies (NCT04235777) | National Cancer Institute (NCI) | 2020-07-13 |
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (NCT04273061) | British Columbia Cancer Agency | 2020-06-17 |
| Parametric PET of Genitourinary Cancer (NCT04020978) | University of California, Davis | 2019-07-16 |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors (NCT04354064) | Washington University School of Medicine | 2019-05-29 |
| An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer (NCT03794635) | Memorial Sloan Kettering Cancer Center | 2018-12-20 |
| Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer (NCT03480152) | National Cancer Institute (NCI) | 2018-05-18 |
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (NCT03333616) | Dana-Farber Cancer Institute | 2017-12-28 |
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (NCT02906943) | University Health Network, Toronto | 2016-08-01 |
| PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer (NCT02735252) | University of California, San Francisco | 2016-05-25 |
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) (NCT02583815) | University of Texas Southwestern Medical Center | 2015-08-01 |
| A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (NCT02222259) | University of Toronto | 2014-09-01 |
| Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) (NCT02060370) | M.D. Anderson Cancer Center | 2014-08-01 |
| Personal Web Page In Clinical Trial Participant Education (NCT03887091) | Dana-Farber Cancer Institute | 2014-07-21 |
| Genomic Investigation of Unusual Responders (NCT03740503) | University Health Network, Toronto | 2013-11-01 |
| Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass (NCT01433302) | M.D. Anderson Cancer Center | 2012-03-01 |
| Integrated Molecular Profiling in Advanced Cancers Trial (NCT01505400) | University Health Network, Toronto | 2012-02-01 |
| Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers (NCT01375699) | Virginia Commonwealth University | 2011-08-11 |
| A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast (NCT00147238) | M.D. Anderson Cancer Center | 2005-07-01 |